07 Jan 2001

Posorutin® (Posorutin® Augentropfen) - Deutschland

Updated: 07 Jan 2001

Posorutin®

Als Adjuvans bei Retinopathia diabetica, Retina- u. Glaskörperblutungen, subkonjunktivale Blutungen u. Thrombosen.

Posorutin® Description, Presentation and Dosage

Posorutin® Description

Posorutin® Drug Class Description

Einzelstoffe

Posorutin® Drug Description

1 ml enth.: Troxerutin 50 mg.

Posorutin® Generic Name

Posorutin® Augentropfen

Posorutin® Presentation

Posorutin® Presentation

Posorutin®

Posorutin® Manufacturer

Ursapharm

Related Learning Zones

Bedwetting Knowledge Centre and CME

Bedwetting Knowledge Centre and CME

The Bedwetting Knowledge Centre, independently reviewed for clinical accuracy by Søren Rittig, MD, DMSc, aims to equip healthcare professionals with the information and guidance they need to effectively diagnose, treat and refer patients with nocturnal enuresis. This mobile-optimised resource contains disease awareness information, best practice guidelines and a CME activity ‘Case Studies in Urology: Best Practice Management of Bedwetting’.

Prostate Cancer Learning Hub

Prostate Cancer Learning Hub

The Prostate Cancer Learning Hub has been designed with the busy healthcare professional in mind. The resource conveniently organises a range of up-to-date education content, reference materials and decision support tools, all focussing on prostate cancer. The disease awareness section provides you with access to a Prostate Cancer Knowledge Centre, which has been developed to provide you with easy to digest best practice guidance for the treatment and management of patients with prostate cancer.

Posorutin® Dosage

Posorutin® Adult Dosage

Chlorhexidindigluconat 0,05 mg (Konservierungsmittel), Natriumchlorid, Dinatriumedetat, Wasser f. Inj.-zwecke.

Posorutin® Precautions, Reactions and Contraindications

Posorutin® Special Precautions

Related Drugs - Eye Health and Disorders

Back to top